2020
Utilization of next-generation sequencing and associated systemic therapy initiation in metastatic prostate cancer.
Yang D, Leapman M, Gross C, Yu J. Utilization of next-generation sequencing and associated systemic therapy initiation in metastatic prostate cancer. Journal Of Clinical Oncology 2020, 38: e19308-e19308. DOI: 10.1200/jco.2020.38.15_suppl.e19308.Peer-Reviewed Original ResearchMetastatic prostate cancerSystemic therapy initiationTherapy initiationNGS test resultsNGS testingSystemic therapyMetastatic diagnosisNGS testsProstate cancerCommon systemic therapySystemic therapy selectionRetrospective observational studyNext-generation sequencing testDe-identified databaseMPC patientsTherapy startClinical outcomesMedian timeTherapy changesTreatment choiceObservational studyTherapy selectionGenomic classifierPatientsTherapy
2014
PS1-44: Time to Surgery for Melanoma
Lott J, Soulos P, Aminawung J, Gross C. PS1-44: Time to Surgery for Melanoma. Clinical Medicine & Research 2014, 12: 78-78. PMCID: PMC4453318, DOI: 10.3121/cmr.2014.1250.ps1-44.Peer-Reviewed Original ResearchCases of melanomaDermatologic careRetrospective cohort studyPatient-level factorsElixhauser Comorbidity IndexICD-9 codesMultivariate logistic regressionSurgical procedure codesMelanoma-related deathHospital referral regionsMedicare administrative claimsClustering of casesPrior melanomaComorbidity indexCohort studySurgical resectionSurgical therapyPrimary outcomeSurgical delayIncident melanomaMedian timeRegional diseaseMedicare databaseCutaneous melanomaSkin biopsies